RALLISNSERallis India Limited· Pesticides And AgrochemicalsMediumNeutral
Announced Mon, 14 Jul · 19:46 IST

Rallis India Limited has informed the Exchange about Investor Presentation

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

RALLIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Rallis India has submitted its Q1 FY26 investor presentation ahead of the earnings call on July 15, 2025. Consolidated revenue rose 22% year-on-year to ₹957 Cr from ₹783 Cr, driven by volume growth and double-digit growth across businesses. EBITDA jumped 57% YoY to ₹150 Cr (from ₹96 Cr) on volume-led growth and controlled fixed costs, while Profit After Tax nearly doubled to ₹95 Cr (from ₹48 Cr). The Crop Care segment posted 16% revenue growth with EBITDA up 47%, and the Seeds segment grew 38% with EBITDA up 67%, supported by strong North cotton (Diggaz) sales though Maize and Paddy faced supply constraints. The company highlighted its long-term ambition of a minimum 15% Innovation Turnover Index and focus on Soil & Plant Health solutions and Custom Synthesis Manufacturing.

Likely market impact

Sharp improvement in both revenue and profits, with EBITDA and PAT nearly doubling, signals strong operational momentum and margin expansion in the seasonally important first quarter, which is positive for shareholder sentiment.